Detalles de la búsqueda
1.
Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up.
Oncologist
; 26(5): e749-e755, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33486783
2.
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies.
Breast Cancer Res
; 22(1): 27, 2020 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164785
3.
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials.
Breast Cancer Res Treat
; 184(1): 23-35, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32783178
4.
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Breast J
; 26(3): 368-375, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31448513
5.
Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2- Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA-2 Trial.
Oncologist
; 24(12): 1514-1525, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31217344
6.
Palbociclib and Letrozole in Advanced Breast Cancer.
N Engl J Med
; 375(20): 1925-1936, 2016 11 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-27959613
7.
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.
Int J Clin Oncol
; 24(3): 274-287, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30515674
8.
Palbociclib has no clinically relevant effect on the QTc interval in patients with advanced breast cancer.
Anticancer Drugs
; 29(3): 271-280, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29360661
9.
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer.
J Clin Oncol
; 42(9): 994-1000, 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38252901
10.
Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
Clin Drug Investig
; 43(9): 699-706, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37594640
11.
Real-World Data of Palbociclib in Combination With Endocrine Therapy for the Treatment of Metastatic Breast Cancer in Men.
Clin Pharmacol Ther
; 111(1): 302-309, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34668577
12.
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.
NPJ Precis Oncol
; 6(1): 56, 2022 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35974168
13.
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).
J Clin Oncol
; 40(3): 282-293, 2022 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34874182
14.
Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naïve Metastatic Breast Cancer.
Clin Cancer Res
; 26(1): 110-121, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31527167
15.
Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 Study.
J Glob Oncol
; 5: 1-19, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31125276
16.
Long-term Pooled Safety Analysis of Palbociclib in Combination With Endocrine Therapy for HR+/HER2- Advanced Breast Cancer.
J Natl Cancer Inst
; 111(4): 419-430, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30032196
17.
Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.
Clin Breast Cancer
; 18(6): e1239-e1245, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30172722
18.
Correction: Expanded Access Study of Palbociclib Plus Letrozole for Postmenopausal Women with HR+/HER2- Advanced Breast Cancer in Latin America for Whom Letrozole Therapy is Deemed Appropriate.
Clin Drug Investig
; 43(9): 707-708, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37695417
19.
Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.
J Natl Cancer Inst
; 103(9): 763-73, 2011 May 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-21527770
Resultados
1 -
19
de 19
1
Próxima >
>>